MIRA PHARMACEUTICALS, Inc.
855 N Wolfe Street, Suite 601
Baltimore, Maryland 21205
December 22, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Alan Campbell
Re: | MIRA Pharmaceuticals, Inc. | |
Registration Statement on Form S-1 | ||
Filed December 18, 2023 | ||
File No. 333-276118 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, MIRA Pharmaceuticals, Inc., hereby requests that the above-referenced Registration Statement on Form S-1 be declared effective at 5:00 p.m., Eastern Standard Time, on Wednesday, December 27, 2023, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Curt Creely of Foley & Lardner LLP of such effectiveness by a telephone call to (813) 225-4122.
Very truly yours, | ||
mira pharmaceuticals, Inc. | ||
By: | /s/ Erez Aminov | |
Erez Aminov | ||
Chief Executive Officer |